Precision and Advanced Nano-Phytopharmaceuticals for Therapeutic Applications

abstract

Phytopharmaceuticals have been widely used globally since ancient times and acknowledged by healthcare professionals and patients for their superior therapeutic value and fewer side-effects compared to modern medicines. However, phytopharmaceuticals need a scientific and methodical approach to deliver their components and thereby improve patient compliance and treatment adherence. Dose reduction, improved bioavailability, receptor selective binding, and targeted delivery of phytopharmaceuticals can be likely achieved by molding them into specific nano-formulations. In recent decades, nanotechnology-based phytopharmaceuticals have emerged as potential therapeutic candidates for the treatment of various communicable and non-communicable diseases. Nanotechnology combined with phytopharmaceuticals broadens the therapeutic perspective and overcomes problems associated with plant medicine. The current review highlights the therapeutic application of various nano-phytopharmaceuticals in neurological, cardiovascular, pulmonary, and gastro-intestinal disorders. We conclude that nano-phytopharmaceuticals emerge as promising therapeutics for many pathological conditions with good compliance and higher acceptance.

keywords

H1N1 INFLUENZA-VIRUS; SILVER NANOPARTICLES; IN-VITRO; METALLIC NANOPARTICLES; PSEUDOMONAS-AERUGINOSA; STAPHYLOCOCCUS-AUREUS; GOLD NANOPARTICLES; GREEN SYNTHESIS; PANAX-GINSENG; CURCUMIN

subject category

Chemistry; Science & Technology - Other Topics; Materials Science; Physics

authors

Lim, CL; Raju, CS; Mahboob, T; Kayesth, S; Gupta, KK; Jain, GK; Dhobi, M; Nawaz, M; Wilairatana, P; Pereira, MD; Patra, JK; Paul, AK; Rahmatullah, M; Nissapatorn, V

our authors

acknowledgements

M.d.L.P. thanks Project CICECO-Aveiro Institute of Materials, UIDB/50011/2020 and UIDP/50011/2020, national funds by FCT/MCTES. J.K.P. is grateful to the National Research Foundation of Korea [NRF] grant funded by the Korea government (MSIT) (No. 2020R1G1A1004667), the Republic of Korea for support.

Share this project:

Related Publications

We use cookies for marketing activities and to offer you a better experience. By clicking “Accept Cookies” you agree with our cookie policy. Read about how we use cookies by clicking "Privacy and Cookie Policy".